Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
- Conditions
- Asthma
- Registration Number
- NCT00024544
- Lead Sponsor
- Facet Biotech
- Brief Summary
The purpose of the study is to evaluate an investigational medication to treat chronic asthma. The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years. Participants in the study will have a number of visits to a research site over an 8-month period. All study-related care and medication is provided to qualified participants at no cost. This includes all visits, examinations and laboratory work.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- At least a 6-month history of asthma
- No use of inhaled, oral or injectable steroids for at least 1 month prior to enrollment
- Patients with > 10 pack years of smoking history or smoking within 12 months of study enrollment
- No significant disease other than asthma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (18)
Allergy Research Foundation
πΊπΈLos Angeles, California, United States
Southern California Research
πΊπΈMission Viejo, California, United States
Clinical Trials of Orange Cnty., Inc.
πΊπΈOrange, California, United States
Allergy Associates Medical Group, Inc.
πΊπΈSan Diego, California, United States
Allergy and Asthma Associates Santa Clara Valley Research Center
πΊπΈSan Jose, California, United States
Bensch Research Associates
πΊπΈStockton, California, United States
National Jewish Medical and Research Center
πΊπΈDenver, Colorado, United States
ICSL Clinical Studies
πΊπΈNormal, Illinois, United States
Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital
πΊπΈBoston, Massachusetts, United States
New England Clinical Studies
πΊπΈN. Dartmouth, Massachusetts, United States
Scroll for more (8 remaining)Allergy Research FoundationπΊπΈLos Angeles, California, United States